Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine versus lidocaine for local anesthesia during PEG placement in head and neck cancer
ACTRN12618000713291Phase 3Recruiting
- Sponsor
- IPO Lisboa
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in head and neck cancer (HNC) comparing Ropivacaine local anesthesia with Lidocaine local anesthesia (2 arms). Started Jan 2018; status: recruiting.
02
Drugs
ropivacainelidocaine
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on ACTRN12618000713291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000713291.